Mandy Wilson is a research scientist at the Biocomplexity Institute at the University of Virginia; prior to that, she was an employee of the Biocomplexity Institute of Virginia Tech from 2008 - 2018. Wilson has had a broad range of work experiences, including custom software development for the federal government and the private sector. She received her undergraduate and master's degrees at Virginia Tech. Wilson’s primary interests are database architectures and data mining, but she is also an expert in graphical user interface design, web development, and design and development of other custom software. She worked as a computational synthetic biologist at the Biocomplexity Institute, developing software to support genomic design and sequencing verification. Wilson was also one of the original editors of the Synthetic Biology Open Language (SBOL) standard, which is a markup language for exchanging genomic data; more on this can be reviewed at http://sbolstandard.org.
Synthetic biology, modeling behavior on social media, epidemiology, database architecture, and data mining
Virginia Tech, English, M.A., 1994
Virginia Tech, Computer Science, B.S., 1992
Virginia Tech, English, B.A., 1991
Researchers at the University of Virginia Biocomplexity Institute are founding partners of a national research institute that will develop artificial intelligence-driven solutions for some of agriculture’s biggest problems: labor, water, weather, and climate change.
New tool provides projections of critical data on bed capacity and hospitalization rates.
Mandy Wilson joined Virginia's First Lady, Pamela Northam, student STEM Advocate, Jordan Wright and other women in science to discuss women in STEM and give advice as to the field.
Will our hospitals have the capacity to care for those who become infected? This question remains at the heart of COVID-19 planning and response discussions everywhere as public health officials and policy makers consider how lifting interventions such as stay-at-home orders will impact a potential resurgence of the disease.
While vaccination is the primary and most effective way to prevent sickness and death caused by flu, the CDC reports that less than 40 percent of Americans age 18 and older typically receive a flu shot. This begs the question: what additional mitigation and prevention methods might improve the public health response and policy development for the flu?